- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
C
CMPS
Compass Pathways Plc
11.81
+0.22+1.90%After Hours: 11.87 +0.06 +0.50%19:59 05/22 EDT
OPEN/PREV CLOSE12.04/11.59
TODAY RANGE11.59-12.24
VOL3.87M
MARKET CAP1.59B
52 WEEK RANGE2.250-12.24
AVG VOL (3M)3.92M
% TURNOVER2.87%
TURNOVER--
P/E (TTM)-5.8920
% RANGE5.57%
EPS(TTM)-2.0044
P/E(FORWARD)-18.7460
P/B4.878
BVPS2.421
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.46B
SHARES OUTSTANDING134.95M
NEXT EARNINGS07/29-08/03
FREE FLOAT123.23M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
COMPASS Pathways (CMPS) Is Up 13.9% After Swinging From Loss To Q1 2026 Profit - What's Changed
Seeking Alpha·05/18 11:17
At a glance: stocks gapping up premarket
Benzinga·05/18 09:38
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Simply Wall St·05/18 08:36
A Look At COMPASS Pathways (CMPS) Valuation After Phase 3 COMP360 Data And Priority Review Voucher
Dow Jones·05/15 20:01
Compass Pathways Is Maintained at Buy by Maxim Group
Dow Jones·05/15 20:01
Compass Pathways Price Target Raised to $20.00/Share From $12.00 by Maxim Group
Benzinga·05/15 19:52
Maxim Group Maintains Buy on Compass Pathways, Raises Price Target to $20
TipRanks·05/15 15:29
H.C. Wainwright Sticks to Their Buy Rating for COMPASS Pathways (CMPS)
TipRanks·05/15 15:28
Compass Pathways price target raised to $20 from $12 at Maxim
Seeking Alpha·05/15 00:36
Compass Pathways: Imminent Commercialization Should Provide Further Upside
Simply Wall St·05/14 22:43
Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift
TipRanks·05/14 18:50
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings